ArticleDiabetes, obesity & metabolism2018

Effect of alirocumab on lipids and lipoproteins in individuals with metabolic syndrome without diabetes: Pooled data from 10 phase 3 trials.

Robert R Henry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.